Point72 Asset Management »

Lyra Therapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $16M 3.0M 5.24

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Meta Platforms Cl A (META)
Dell Technologies CL C (DELL)
Union Pacific Corporation (UNP)
Boston Scientific Corporation (BSX)
Johnson Ctls Intl SHS (JCI)
NVIDIA Corporation (NVDA)
FedEx Corporation (FDX)
Microsoft Corporation (MSFT)
CSX Corporation (CSX)
Honeywell International (HON)
Thermo Fisher Scientific (TMO)
Oracle Corporation (ORCL)
Western Digital (WDC)

View all positions for Point72 Asset Management

Top funds holding Lyra Therapeutics

Perceptive Advisors
Nantahala Capital Management
Point72 Asset Management
Citadel Advisors
Samsara BioCapital
VR Adviser
Ikarian Capital
Rosalind Advisors
Vanguard Group
Millennium Management
Alyeska Investment Group
Bank of America Corporation
Two Sigma Investments
Citigroup
Clearline Capital

View all funds holding Lyra Therapeutics